Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00500838 · ClinicalTrials.gov registry record · NA
Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study
A NA study of Heart Failure, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 4
- Study locations
NCT00500838 is a NA study of Heart Failure that has completed, run by Abbott Medical Devices. The registered enrollment target is 75 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT00500838, a NA study of Heart Failure, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 4
- Study locations
Study Summary
The intent of this feasibility study is to collect and analyze intra-thoracic impedance measurements from a CRT-D device in a heart failure population.
Conditions Studied
Interventions
- DEVICE Transthoracic Impedance
Study Locations (4)
Arkansas
- Baptist Health Medical Center - Little Rock
California
- Glendale Memorial Hospital - Glendale
New Jersey
- Deborah Heart and Lung - Browns Mills
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00500838
The ClinicalTrials.gov registry entry for NCT00500838 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Transthoracic Impedance is the first listed.
NCT00500838 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Arkansas, California, New Jersey.
Frequently Asked Questions
What is clinical trial NCT00500838 about?
NCT00500838 is a clinical study titled "Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study". The intent of this feasibility study is to collect and analyze intra-thoracic impedance measurements from a CRT-D device in a heart failure population.
What is the current status of trial NCT00500838?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2007-07. Estimated completion is 2008-08.
What conditions does trial NCT00500838 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT00500838?
The interventions under investigation include: Transthoracic Impedance (DEVICE).
Who is sponsoring clinical trial NCT00500838?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00500838 being conducted?
This trial has 4 study locations across Arkansas, California, New Jersey, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.